FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109442907> ?p ?o ?g. }

• W2109442907 endingPage "604" @default.
• W2109442907 startingPage "597" @default.
• W2109442907 abstract "Background Remote ischaemic preconditioning has been associated with reduced risk of myocardial injury after coronary artery bypass graft (CABG) surgery. We investigated the safety and efficacy of this procedure. Methods Eligible patients were those scheduled to undergo elective isolated first-time CABG surgery under cold crystalloid cardioplegia and cardiopulmonary bypass at the West-German Heart Centre, Essen, Germany, between April, 2008, and October, 2012. Patients were prospectively randomised to receive remote ischaemic preconditioning (three cycles of 5 min ischaemia and 5 min reperfusion in the left upper arm after induction of anaesthesia) or no ischaemic preconditioning (control). The primary endpoint was myocardial injury, as reflected by the geometric mean area under the curve (AUC) for perioperative concentrations of cardiac troponin I (cTnI) in serum in the first 72 h after CABG. Mortality was the main safety endpoint. Analysis was done in intention-to-treat and per-protocol populations. This trial is registered with ClinicalTrials.gov, number NCT01406678. Findings 329 patients were enrolled. Baseline characteristics and perioperative data did not differ between groups. cTnI AUC was 266 ng/mL over 72 h (95% CI 237–298) in the remote ischaemic preconditioning group and 321 ng/mL (287–360) in the control group. In the intention-to-treat population, the ratio of remote ischaemic preconditioning to control for cTnI AUC was 0·83 (95% CI 0·70–0·97, p=0·022). cTnI release remained lower in the per-protocol analysis (0·79, 0·66–0·94, p=0·001). All-cause mortality was assessed over 1·54 (SD 1·22) years and was lower with remote ischaemic preconditioning than without (ratio 0·27, 95% CI 0·08–0·98, p=0·046). Interpretation Remote ischaemic preconditioning provided perioperative myocardial protection and improved the prognosis of patients undergoing elective CABG surgery. Funding German Research Foundation. Remote ischaemic preconditioning has been associated with reduced risk of myocardial injury after coronary artery bypass graft (CABG) surgery. We investigated the safety and efficacy of this procedure. Eligible patients were those scheduled to undergo elective isolated first-time CABG surgery under cold crystalloid cardioplegia and cardiopulmonary bypass at the West-German Heart Centre, Essen, Germany, between April, 2008, and October, 2012. Patients were prospectively randomised to receive remote ischaemic preconditioning (three cycles of 5 min ischaemia and 5 min reperfusion in the left upper arm after induction of anaesthesia) or no ischaemic preconditioning (control). The primary endpoint was myocardial injury, as reflected by the geometric mean area under the curve (AUC) for perioperative concentrations of cardiac troponin I (cTnI) in serum in the first 72 h after CABG. Mortality was the main safety endpoint. Analysis was done in intention-to-treat and per-protocol populations. This trial is registered with ClinicalTrials.gov, number NCT01406678. 329 patients were enrolled. Baseline characteristics and perioperative data did not differ between groups. cTnI AUC was 266 ng/mL over 72 h (95% CI 237–298) in the remote ischaemic preconditioning group and 321 ng/mL (287–360) in the control group. In the intention-to-treat population, the ratio of remote ischaemic preconditioning to control for cTnI AUC was 0·83 (95% CI 0·70–0·97, p=0·022). cTnI release remained lower in the per-protocol analysis (0·79, 0·66–0·94, p=0·001). All-cause mortality was assessed over 1·54 (SD 1·22) years and was lower with remote ischaemic preconditioning than without (ratio 0·27, 95% CI 0·08–0·98, p=0·046). Remote ischaemic preconditioning provided perioperative myocardial protection and improved the prognosis of patients undergoing elective CABG surgery." @default.
• W2109442907 created "2016-06-24" @default.
• W2109442907 creator A5026182510 @default.
• W2109442907 creator A5026578073 @default.
• W2109442907 creator A5034749915 @default.
• W2109442907 creator A5035620570 @default.
• W2109442907 creator A5042457524 @default.
• W2109442907 creator A5062418579 @default.
• W2109442907 creator A5065018686 @default.
• W2109442907 creator A5065197809 @default.
• W2109442907 creator A5076082024 @default.
• W2109442907 creator A5077227994 @default.
• W2109442907 creator A5085106774 @default.
• W2109442907 creator A5090617573 @default.
• W2109442907 date "2013-08-01" @default.
• W2109442907 modified "2023-10-11" @default.
• W2109442907 title "Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial" @default.
• W2109442907 cites W125028120 @default.
• W2109442907 cites W1824177875 @default.
• W2109442907 cites W1968832307 @default.
• W2109442907 cites W1997775629 @default.
• W2109442907 cites W2000662838 @default.
• W2109442907 cites W2001892814 @default.
• W2109442907 cites W2004640561 @default.
• W2109442907 cites W2005838521 @default.
• W2109442907 cites W2022473516 @default.
• W2109442907 cites W2056190116 @default.
• W2109442907 cites W2063035151 @default.
• W2109442907 cites W2077467880 @default.
• W2109442907 cites W2082327290 @default.
• W2109442907 cites W2092514842 @default.
• W2109442907 cites W2096389716 @default.
• W2109442907 cites W2097913246 @default.
• W2109442907 cites W2099501766 @default.
• W2109442907 cites W2111476570 @default.
• W2109442907 cites W2122179672 @default.
• W2109442907 cites W2136272230 @default.
• W2109442907 cites W2140750664 @default.
• W2109442907 cites W2144448307 @default.
• W2109442907 cites W2144656835 @default.
• W2109442907 cites W2148778286 @default.
• W2109442907 cites W2156123275 @default.
• W2109442907 cites W2156495678 @default.
• W2109442907 cites W2328044674 @default.
• W2109442907 doi "https://doi.org/10.1016/s0140-6736(13)61450-6" @default.
• W2109442907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23953384" @default.
• W2109442907 hasPublicationYear "2013" @default.
• W2109442907 type Work @default.
• W2109442907 sameAs 2109442907 @default.
• W2109442907 citedByCount "400" @default.
• W2109442907 countsByYear W21094429072013 @default.
• W2109442907 countsByYear W21094429072014 @default.
• W2109442907 countsByYear W21094429072015 @default.
• W2109442907 countsByYear W21094429072016 @default.
• W2109442907 countsByYear W21094429072017 @default.
• W2109442907 countsByYear W21094429072018 @default.
• W2109442907 countsByYear W21094429072019 @default.
• W2109442907 countsByYear W21094429072020 @default.
• W2109442907 countsByYear W21094429072021 @default.
• W2109442907 countsByYear W21094429072022 @default.
• W2109442907 countsByYear W21094429072023 @default.
• W2109442907 crossrefType "journal-article" @default.
• W2109442907 hasAuthorship W2109442907A5026182510 @default.
• W2109442907 hasAuthorship W2109442907A5026578073 @default.
• W2109442907 hasAuthorship W2109442907A5034749915 @default.
• W2109442907 hasAuthorship W2109442907A5035620570 @default.
• W2109442907 hasAuthorship W2109442907A5042457524 @default.
• W2109442907 hasAuthorship W2109442907A5062418579 @default.
• W2109442907 hasAuthorship W2109442907A5065018686 @default.
• W2109442907 hasAuthorship W2109442907A5065197809 @default.
• W2109442907 hasAuthorship W2109442907A5076082024 @default.
• W2109442907 hasAuthorship W2109442907A5077227994 @default.
• W2109442907 hasAuthorship W2109442907A5085106774 @default.
• W2109442907 hasAuthorship W2109442907A5090617573 @default.
• W2109442907 hasConcept C115725540 @default.
• W2109442907 hasConcept C126322002 @default.
• W2109442907 hasConcept C141071460 @default.
• W2109442907 hasConcept C164705383 @default.
• W2109442907 hasConcept C168563851 @default.
• W2109442907 hasConcept C203092338 @default.
• W2109442907 hasConcept C2775901492 @default.
• W2109442907 hasConcept C2776820930 @default.
• W2109442907 hasConcept C2778789114 @default.
• W2109442907 hasConcept C2778881276 @default.
• W2109442907 hasConcept C2779311647 @default.
• W2109442907 hasConcept C2908647359 @default.
• W2109442907 hasConcept C31174226 @default.
• W2109442907 hasConcept C42219234 @default.
• W2109442907 hasConcept C500558357 @default.
• W2109442907 hasConcept C541997718 @default.
• W2109442907 hasConcept C71924100 @default.
• W2109442907 hasConcept C76318530 @default.
• W2109442907 hasConcept C99454951 @default.
• W2109442907 hasConceptScore W2109442907C115725540 @default.
• W2109442907 hasConceptScore W2109442907C126322002 @default.
• W2109442907 hasConceptScore W2109442907C141071460 @default.
• W2109442907 hasConceptScore W2109442907C164705383 @default.
• W2109442907 hasConceptScore W2109442907C168563851 @default.

• next